Drug–drug Interactions Between Anti-Retroviral Therapies and Drugs of Abuse in HIV Systems

Expert Opinion on Drug Metabolism and Toxicology - United Kingdom
doi 10.1517/17425255.2015.996546
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

HIV/AIDS Treatment Is Easier but Drug-Drug Interactions?

Mediterranean Journal of Infection, Microbes and Antimicrobials
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2019English

Epigenetics, Drugs of Abuse, and the Retroviral Promoter

Journal of NeuroImmune Pharmacology
NeuroscienceAllergyImmunologyPharmacology
2013English

Comparative Study of Drug Efficacy and Drug Additives Between Generic Drugs and Original Drugs

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2007English

Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance With HIV Therapies

Journal of Medical Toxicology
MutagenesisToxicologyHealth
2010English

Synthesis of Anti-Hiv Polymer Drug.

Kobunshi
Materials SciencePolymersPlasticsChemical EngineeringEnvironmental Science
1992English

Neutralizing Antibody and Anti-Retroviral Drug Sensitivities of HIV-1 Isolates Resistant to Small Molecule CCR5 Inhibitors

Virology
Virology
2008English

Novel Anti-Retroviral Drug Targets: Interfering siRNA and Mitochondrial TERT Expression

Virology & Mycology
2016English

Clinically Significant Interactions Between Antiretroviral and Co-Prescribed Drugs for HIV-infected Children: Profiling and Comparison of Two Drug Databases

Therapeutics and Clinical Risk Management
2013English

Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy